INTRODUCTION
Polymeric matrix systems are most commonly used for controlled release of drug. Hydrophilic and hydrophobic polymers and their different combinations are used to manipulate the drug release. Polymers sensitive to different stimuli such as temperature, pH, enzymes, and ions are used to control site and rate of drug release. [1] [2] [3] [4] The κ-carrageenan exists either in the coil or helix confirmation and can undergo a thermal as well as salt-induced helixcoil transformation. This order-disorder transition of κ-carrageenan was found to be dependent on specific types of cations and anions used. A helix-helix aggregation that is responsible for gel formation relies on a specific cation present. Potassium ions have the capacity to induce helix confirmation and promote helix-helix aggregation, thereby facilitating gel formation. Ca 2+ or K + can screen electrostatic repulsive forces between the participating chains, by packing within the aggregate structure. As the level of potassium increases, the structure becomes tightly aggregated, exhibiting increase in gel strength. 16 Carrageenan, a polymer widely used in food industry has been recently studied for its applications for controlled drug delivery. 3 Carrageenans are hydrophilic, high molecular weight, anionic linear heteropolysaccharides extracted from marine algae Rhodophyceae. There are different types of carrageenans but kappa (κ), iota (ι), and lambda (λ) are used for pharmaceutical applications. Carrageenans are sulfate
The κ-carrageenan has been evaluated for compressional properties and was found to exhibit viscoelastic behavior.
11, 17 Due to its gelling property, it has been studied as a release retardant for ionic and nonionic drugs.
11, 13 Picker studied the effect of added cation on the properties of 2 varieties of κ-carrageenan as well as using theophylline and diclofenac sodium as model drugs. 18 Sjöberg et al studied the effect of κ-carrageenan on the diffusional transport of positively charged drugs in agarose gels. Likewise, changes in the diffusion coefficient during simultaneous diffusion of 2 drugs was also studied. 19 Because cations play an important role in the properties of the κ-carrageenan matrix, presence of cationic drugs will cause significant changes in its properties. Similarly, the effect of other cations such as K + used for gelling, may be significantly altered due to cationic drug. There are very few reports on the application of κ-carrageenan as a carrier for cationic drugs. 13 Therefore, the aim of the present study is to study the effect of KCl and the cationic model drug, metformin HCl, on the water uptake, erosion, and release of drug and potassium ions from the κ-carrageenan matrix.
MATERIALS AND METHODS

Materials
The κ-carrageenan (GP 911 NF) was a generous gift from FMC Corporation, Philadelphia, PA (through Signet Chem, Mumbai, India). Lupin Research Park (Pune, India) provided metformin HCl as a gift sample. All other chemicals were purchased and were of analytical grade.
Methods
Preparation of Plain Matrices
The κ-carrageenan (50 g) was mixed with different amounts of potassium chloride in a laboratory mixer (Seema Enterprises, Pune, India) to obtain the powder mix containing 2.5% to 13.75% wt/wt potassium chloride. The mixture was passed through a 40-mesh screen. Suitable quantity of powder mixture was weighed and compressed at 100 kg/cm 2 for 60 seconds using KBr press (Spectra Lab, Mumbai, India) to obtain compacts, each containing 400 mg κ-carrageenan. Different batches were coded as K0, K2.5, and so on depending on potassium chloride concentration (suffix denotes KCl concentration).
Preparation of Drug-Loaded Matrices
Metformin HCl and κ-carrageenan were mixed in the ratio 1:4 in a laboratory mixer. Fifty grams of this mixture was then mixed with different amounts of potassium chloride to obtain powder mixture containing 2.5% to 13.75% wt/wt of potassium chloride. The powder was compressed in the same manner as for plain matrices. Drug-loaded matrices were coded as KD0, KD2.5, and so on depending on the potassium chloride concentration.
Evaluation
Water-Uptake Study
Water-uptake studies were performed by equilibrium weight gain method. 20 The studies were performed using United States Pharmacopeia (USP) 24 type I dissolution test apparatus (TDT 08L, Electrolab, Mumbai, India). The matrices were accurately weighed and placed in a dissolution basket. The baskets were immersed in a dissolution vessel containing 900 mL deionized water maintained at 37°C ± 0.5°C; speed of rotation was 100 rpm. At regular intervals, the basket-matrix systems were removed from the dissolution vessels, blotted with tissue paper to remove excess water, and reweighed. The percentage water uptake (ie, the degree of swelling due to absorbed water) was calculated using Equation 1: (1) where, W i and W s represent initial weight of the matrix and swollen matrix at time t, respectively; W p and W pe denote initial weight of the polymer added to the matrix and weight of polymer eroded up to time t, respectively; and W e represents the total weight loss due to dissolution of drug, KCl, and polymer from the matrix up to time t. Drug loss was excluded during calculations for plain matrices. Studies were performed using 5 matrices.
Erosion Study
Erosion studies of plain and drug-loaded matrices were performed as reported by Roy and Rohera. 20 The preweighed matrices were placed in the dissolution basket and subjected to dissolution in 900 mL deionized water maintained at 37°C ± 0.5°C, speed of rotation was 100 rpm. At regular intervals, the basket-matrix systems were removed from the dissolution media and dried to constant weight in hot air oven at 50°C. The percentage matrix erosion (E) at time t was calculated using Equation 2:
where, W dp is total weight of drug and polymer lost up to time t, and W t is weight of dried partially eroded matrix at time t. D and P represent initial weight of drug and polymer added to the matrix; D was excluded from Equation 2 for plain matrices. The average values of 5 readings were obtained.
In Vitro Release Study
Release of potassium chloride and drug from the matrices was performed using USP 24 type II dissolution test apparatus. The matrices were placed at the bottom of a dissolution vessel containing 900 mL of water maintained at 37°C ± 0.5°C; speed of rotation was 100 rpm. Samples were collected periodically and replaced with fresh medium. Solutions were filtered through Whatman filter paper 41 (Springfield Mill, UK) and concentration of metformin HCl was determined spectrophotometrically at 233 nm (Jasco V500, Tokyo, Japan). Amount of potassium chloride released was calculated by estimation of potassium flame photometrically (Flame Photometer 130, Systronics, Ahmedabad, India).
Release studies were performed in triplicate.
RESULTS AND DISCUSSION
Water Uptake
Water-uptake profiles of plain and drug-containing matrices having different concentrations of KCl are shown in Figures  1 and 2 , respectively. Water uptake by the matrix was calculated using Equation 1. As compared with previous reports, 20 this equation takes into consideration drug release and matrix erosion or dissolution, reflecting only the changes due to water uptake. A plain matrix without KCl (ie, batch K0) did not show any significant water uptake and disintegrated within 4 hours. Batch KD0 showed significant increase in water uptake as compared with K0 and maintained integrity for up to 6 hours. This finding may be because of the coil-helix transition and helix-helix association induced by the cationic drug metformin HCl. Except for batch KD0, water uptake was lower for drug-loaded matrices as compared with corresponding plain matrices.
The effect of concentration of KCl alone and in the presence of drug on water uptake at different time intervals is shown in Figures 3 and 4 , respectively. The figures clearly show that water uptake increases linearly with KCl concentration in plain matrices up to 2 hours, after which it deviates from linearity. Where as good correlation was observed in water uptake upto KCl concentration in the range of 2.5 to 10% wt/wt, above which it reduced in drug loaded matrices. Thus, in presence of drug in matrices containing higher KCl concentration, matrix cohesivity is reduced, causing reduced capacity to hold water. The rate of increase in water uptake with KCl concentration was found to be significantly low for drug-loaded batches as compared with plain matrices. After 2 hours, water uptake did not correlate with the concentration of KCl. This finding may be attributed to the changes in gel structure after 2 hours. After 3 hours, matrices showed reduction in cohesivity, especially those containing higher concentration of KCl, and they showed a decline in water uptake. Water uptake data of batches followed the Vergnaud model. The generalized form of the Vergnaud model is as follows:
where M t represents the amount of liquid transferred at time t, and k is the swelling constant, which depends on the 
Erosion Study
The results of plain matrix erosion are shown in Figure 5 . The percentage weight loss of the matrices increased with time. Erosion data were fitted into zero order equation, and regression parameters of various batches are summarized in Table 2 . The slope indicates the rate of erosion, and the intercept gives reflection of erosion in the initial stages. The plain matrices prepared without potassium chloride showed less erosion in the initial stage and a faster rate of erosion, as compared with the matrices containing potassium chloride.
This finding may be attributed to a lack of swelling in the absence of KCl. Concentration of KCl in the matrix did not significantly affect the rate or amount of erosion in the initial stages of plain matrices.
The erosion profiles of plain matrices show that there is deviation from linearity at a certain time within 2 to 3 hours. There was a sudden increase in erosion, but matrices containing more than 8.75% wt/wt potassium chloride showed linear increase in erosion. The results of drug-loaded matrix erosion are shown in Figure 6 . The drug-loaded matrix without potassium chloride showed significant decrease in erosion rate. This result may be attributed to increased water uptake and, in turn, matrix cohesion due to incorporation of drug. For matrices containing potassium chloride, the erosion profile of those containing 5% wt/wt and 6.25% wt/wt followed complete linearity, whereas other batches showed a sudden rise in erosion. Water-uptake and erosion studies indicated that the concentration of potassium chloride significantly affects water uptake but not erosion. Metformin HCl also showed significant effect on water uptake and erosion. Thus, it is necessary to further elucidate the mutual effects of both the components on drug release. Hence release data were obtained to study the effect of drug and potassium chloride on mutual release.
Release Study
Changes in the amount of KCl remaining in plain and drugloaded matrices are shown in Figures 7 and 8 , respectively. In both cases, the amount of KCl retained in the matrix increased with the concentration of KCl added. Release of KCl increased significantly in the presence of drug for batches containing up to 7.5% wt/wt KCl. At higher concentrations, release rate was independent of KCl concentration. This result may be due to reduction in matrix cohesivity at higher KCl concentrations. Drug release from the matrix system was found to decrease with KCl concentration up to 5% wt/wt, above which the drug release increased again ( Figure 9 ). A previous report on the effect of KCl concentration on theophylline, a neutral drug, showed an increase in drug release due to a decrease in matrix cohesivity after 8% wt/wt 18 . Thus concentration of KCl hampering matrix cohesivity has been decreased to 5% wt/wt in presence of cationic drug metformin HCl. The drug may compete with KCl for carrageenan binding, causing increase in KCl release. Hence, matrix cohesivity was reduced at lower KCl concentration because of a significant amount of other cation present in the system. Thus, optimum KCl concentration was found to be 5% wt/wt. Furthermore, it may be hypothesized that charge and size of cation may also the affect matrix property and, in turn, release of KCl and drug. 
CONCLUSION
It may be concluded from the present study that cationic drug significantly affects water uptake and erosion of carrageenan matrices. In the presence of metformin HCl, the cohesivity of matrices was reduced above 5% wt/wt KCl content. Studies on the effect of size and charge on cationic drug may further elucidate the cause of this effect.
